[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.124.106. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 1, 2006

Urine Telomerase and Bladder Cancer Detection

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;295(9):998-999. doi:10.1001/jama.295.9.998-a

To the Editor: Dr Sanchini and colleagues1 studied the relevance of urine telomerase in the diagnosis of bladder cancer. The authors expressed telomerase activity in arbitrary enzymatic units (AEU), which added the potential benefit of a quantitative cutoff or baseline value to the telomeric repeat amplification protocol (TRAP) assay. The quantification of telomerase activity, expressed as AEU, may allow for a more rigorous interpretation of the results and facilitate the clinical use of telomerase activity as a biomarker for cancer.

First Page Preview View Large
First page PDF preview
First page PDF preview
×